Related Experiment Video

Updated: Jun 26, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

DNA methylation and aberrant expression of Sprouty1 in human prostate cancer

Bernard Kwabi-Addo1, Chengxi Ren, Michael Ittmann

  • 1Howard University Cancer Center, NW Washington, DC 20060, USA. bkwabi-addo@howard.edu

Epigenetics
|January 24, 2009
PubMed

Insights

DNA methylation silences Sprouty1, a tumor suppressor, in prostate cancer (PCa). This epigenetic silencing leads to reduced Sprouty1 expression, promoting PCa growth. Understanding this mechanism is key for PCa treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Sprouty1 acts as a negative regulator of fibroblast growth factor signaling.
  • Sprouty1 exhibits tumor suppressor functions in prostate cancer (PCa).
  • Sprouty1 is observed to be downregulated in human PCa, inhibiting proliferation in vitro.

Purpose of the Study:

  • To investigate the role of DNA methylation in regulating Sprouty1 expression in human prostate tumors.
  • To determine if epigenetic modifications contribute to the observed downregulation of Sprouty1 in PCa.

Main Methods:

  • Quantitative measurement of Sprouty1 promoter methylation using pyrosequencing in prostate tissues and cell lines.
  • Assessment of Sprouty1 mRNA expression via quantitative RT-PCR.
  • Functional analysis of promoter methylation using Sss1 methylase and 5'-Aza-2'-Deoxycytidine treatment.

Main Results:

  • Significantly higher Sprouty1 promoter methylation in PCa tissues compared to matched normal tissues.
  • Hypermethylation of the Sprouty1 promoter was also detected in PCa cell lines.
  • Increased Sprouty1 promoter methylation correlated with reduced Sprouty1 mRNA expression in PCa tissues and cell lines.
  • In vitro experiments confirmed that DNA methylation silences Sprouty1 promoter activity, while demethylation restores its expression.

Conclusions:

  • DNA methylation in the Sprouty1 promoter region is a key mechanism responsible for the downregulation of Sprouty1 in prostate cancer.
  • Epigenetic silencing of Sprouty1 contributes to prostate cancer development.
  • Targeting DNA methylation could be a potential therapeutic strategy for PCa.

More Related Videos

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...